ProQR Therapeutics (PRQR) Interest Coverage Ratio (2014 - 2026)
ProQR Therapeutics (PRQR) posted quarterly Interest Coverage Ratio of 290.4 for Q1 2026, down 463.84% year-on-year from 79.82 in Q1 2025, and down 5323.73% on a QoQ basis from 5.35 in Q4 2025.
ProQR Therapeutics (PRQR) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
ProQR Therapeutics (PRQR) has reported Interest Coverage Ratio for 12 consecutive years, with 290.4 the latest figure, recorded in Q1 2026.
- Quarterly Interest Coverage Ratio fell 463.84% year-over-year to 290.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 28.1 (down 57.02% YoY) and the FY2025 annual result came in at 33.76, down 20.09% from the prior year.
- Interest Coverage Ratio retreated to 290.4 in Q1 2026 per PRQR's latest filing, from 5.35 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for PRQR reached as high as 74.73 in Q3 2025 and fell as low as 290.4 in Q1 2026.
- A 4-year average of 33.46 and a median of 5.35 in 2025 frame the typical range for Interest Coverage Ratio.
- The largest YoY upside for Interest Coverage Ratio was 87.76% in 2025 against a maximum downside of 1143.22% in 2025.
- Year by year, Interest Coverage Ratio stood at 1.44 in 2022, then slumped by 319.03% to 6.02 in 2024, then rose by 11.04% to 5.35 in 2025, then slumped by 5323.73% to 290.4 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 290.4, 5.35, and 74.73 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | ProQR Therapeutics | 219.53 Mn | 175.72 Mn | - | -290.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -290.40 |
| Dec 31, 2025 | -5.35 |
| Sep 30, 2025 | 74.73 |
| Jun 30, 2025 | -235.56 |
| Mar 31, 2025 | -51.50 |
| Dec 31, 2024 | -6.02 |
| Sep 30, 2024 | 39.80 |
| Jun 30, 2024 | -18.95 |
| Mar 31, 2024 | 42.72 |
| Dec 31, 2022 | -1.44 |
| Sep 30, 2022 | 18.14 |
| Jun 30, 2022 | 12.80 |
| Mar 31, 2022 | -13.98 |
| Dec 31, 2021 | 32.39 |
| Sep 30, 2021 | 25.95 |
| Jun 30, 2021 | 22.96 |
| Mar 31, 2021 | 20.94 |
| Dec 31, 2020 | 23.06 |
| Sep 30, 2020 | 19.09 |
| Jun 30, 2020 | 98.79 |